Shareholding disclosure

New Leaf Venture Management III LLC

Declared position

7.05%

Threshold

Crossed upwards

Timeline

Published

25.05.2019

Transaction

21.05.2019

Voting rights breakdown

Voting rights acquired7.05%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAJ5O00037

Beneficial owner

New Leaf Venture Management III LLC

Declared address

New Leaf Venture Management III LLC,, DE 19801 Wilmington

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

New Leaf Venture Management III LLC

Addex Therapeutics Ltd25.05.2019TAJ5O00037

Disclosure summary

New Leaf Venture Management III LLC disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 25.05.2019, at 7.05% of voting rights. Notice category: Single shareholder.

Disclosed position

7.05%

Voting rights acquired

Voting rights acquired7.05%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

New Leaf Venture Management III LLC disclosed a holding in Addex Therapeutics Ltd, published on 25.05.2019.

Publication date25.05.2019

Transaction date21.05.2019

Issuing companyAddex Therapeutics Ltd

Beneficial ownerNew Leaf Venture Management III LLC

Declared addressNew Leaf Venture Management III LLC,, DE 19801 Wilmington

CategorySingle shareholder

Voting rights acquired7.05%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAJ5O00037

Source: SIX Exchange Regulation · Publication date: 25.05.2019

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open